10.01.2011 • NewsJohnson & Johnson

Smith & Nephew Rejects $11 Billion Bid from Johnson & Johnson

British medical equipment company Smith & Nephew rejected a 7 billion pound ($10.9 billion) takeover approach from U.S. rival Johnson & Johnson late last year, Sky News said, without citing sources.

Sky said Johnson & Johnson (J&J) was considering whether to return with a higher offer, after its indicative bid of more than 750 pence a share was turned down as too low.

No one at Smith & Nephew (S&N), which is regularly tipped as a bid target for U.S. rivals such as privately owned Biomet, was immediately available for a comment. Bill Price, a J&J spokesman, said the company as a matter of policy does not comment on "rumors and speculation."

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.